Psychosocial well-Being of Patients with Inoperable Non-Small Cell Lung Cancer: The importance of treatment- and disease-related factors
- 1 January 1988
- journal article
- clinical trial
- Published by Taylor & Francis in Acta Oncologica
- Vol. 27 (6) , 829-835
- https://doi.org/10.3109/02841868809094368
Abstract
Patients with inoperable non-small cell lung cancer, limited disease, were randomized to either chemotherapy (cisplatin and etoposide) or radiotherapy of the thorax. A set of questionnaires, covering 4 areas: psychosocial well-being, medical side effects, physical function, and everyday activity was filled out by 101 patients. The correlations between psychosocial well-being (dependent variable) on the one hand, and medical side effects, physical function, and everyday activity (independent variables) on the other were subjected to multiple regression analysis. No significant correlation was found between psychosocial well-being and chemotherapy- or radiotherapy-related subjective side effects. The disease-related symptoms correlated highly with psychosocial well-being during the observation period. Psychosocial well-being and the independent variables tended to be more strongly correlated during the follow-up period (14-52 weeks) than during the treatment period.Keywords
This publication has 21 references indexed in Scilit:
- Validation of a quality of life questionnaire for use in clinical trials for treatment of patients with inoperable lung cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Toxicity, Physical Function and Everyday Activity Reported by Patients with Inoperable Non-Small Cell Lung Cancer in a Randomized Trial (Chemotherapy Versus Radiotherapy)Acta Oncologica, 1988
- Quality of Life of Lung Cancer Patients in a Randomized Clinical Trial Evaluated by a Psychosocial Well-Being QuestionnaireActa Oncologica, 1988
- A randomized study evaluating radiotherapy versus chemotheraphy in patients with inoperable non-small cell lung cancerRadiotherapy and Oncology, 1988
- Psychological impact of adjuvant chemotherapy in the first two years after mastectomy.BMJ, 1986
- Cis-platinum and vindesine in combination in the treatment of non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1985
- On the receiving end—II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Assessment of the quality of life of patients with advanced cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Improved survival of patients with unresectable non-small-cell bronchogenic carcinoma by an innovated high-doseEn-Bloc radiotherapeutic approachCancer, 1981